
|Articles|July 1, 2016 (Updated: November 15, 2020)
- Pharmaceutical Executive-07-01-2016
- Volume 36
- Issue 7
Pharmaceutical Executive, July 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Keeper of the Name: Bayer's Habib Dableover 9 years ago
Worlds Beyond the Clinicover 9 years ago
'PRIME' Time for Medicines in the EUover 9 years ago
Pill Countersover 9 years ago
Country Report: Italy, Part 2Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5




